KLP Kapitalforvaltning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83.8M Sell
2,983,732
-90,200
-3% -$2.4M 0.33% 51
2025
Q4
$76.5M Sell
3,073,932
-15,800
-0.5% -$398K 0.3% 57
2025
Q3
$78.7M Buy
3,089,732
+82,300
+3% +$2.03M 0.31% 51
2025
Q2
$72.9M Buy
3,007,432
+289,900
+11% +$6.76M 0.31% 52
2025
Q1
$68.9M Sell
2,717,532
-1,800
-0.1% -$47.1K 0.34% 50
2024
Q4
$72.1M Buy
+2,719,332
New +$73.8M 0.34% 44

Other funds holding PFE

KLP Kapitalforvaltning's PFE Position: Q1 2026 in Review

KLP Kapitalforvaltning reduced its Pfizer (PFE) stake by 2.9% in Q1 2026, selling an estimated $2.4M and leaving 2,983,732 shares worth $83.8M. The position accounts for 0.33% of the portfolio, ranked #51.

KLP Kapitalforvaltning first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • KLP Kapitalforvaltning held 2,983,732 shares of Pfizer worth $83.8M as of Q1 2026.
  • KLP Kapitalforvaltning sold 90,200 Pfizer shares in Q1 2026, an estimated $2.4M.
  • Pfizer made up 0.33% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #51 holding.
  • KLP Kapitalforvaltning first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.